Insulin List Prices Would Be Lowered To 2006 Levels Under House Bill

 
• By Cathy Kelly

Rebates would be prohibited and insurance coverage required without restrictions for insulin products with steep price roll-backs under bill from Reps. Diana DeGette, D-CO, and Tom Reed, R-NY.

Insulin pen
Bill Would Prohibit Rebates In Return For Lower Prices

More from Pricing Debate

More from Market Access